Ro.co vs bmiMD: Wegovy Pill Access vs Compounded Tirzepatide
Comparing Ro.co vs bmiMD quickly: Ro.co stands out for offering the FDA-approved Wegovy oral GLP-1 and a $39 get-started option, while bmiMD focuses on compounded tirzepatide with multi-month pricing options and free shipping. Early verdict: choose Ro.co if you want an FDA-approved oral pill and regulatory assurance; choose bmiMD if lower monthly equivalents with multi-month commitments and free shipping matter more.
Start with Ro.co for Wegovy access
How Ro.co vs bmiMD differ at a glance
This comparison focuses on the most distinctive differences supported by the sources: medication type and regulatory status, pricing structure and commitments, shipping and subscription features, clinician review and eligibility language, and best-for guidance.
Medication type and regulatory status
Ro.co: Offers the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication. The source emphasizes that Wegovy is an FDA-approved finished medication, not compounded. Treatment is available only when a licensed clinician determines it is medically appropriate. The source notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
bmiMD: Offers compounded tirzepatide, labeled as compounded GLP-1/GIP. The source repeatedly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment is available only when a licensed clinician determines it is medically appropriate.
Pricing structure and commitments
Ro.co: Advertised “Get Started Online for Just $39” as the entry point. The source warns that branded and FDA-approved medications carry higher ongoing costs than compounded alternatives and that ongoing medication pricing depends on the treatment plan and medication prescribed. Ro.co discloses pricing before completing the consultation per the captured FAQ.
bmiMD: Lists four billing options and specific monthly prices: $179 month-to-month; $159 per month on a three-month plan; $149 per month on a six-month plan; and $139 per month on a 12-month plan. The source warns that the lowest price requires a 12-month commitment and advises confirming total prepaid charge and eligibility.
Comparison table: Ro.co vs bmiMD
| Criteria | Ro.co | bmiMD |
|---|---|---|
| Medication type | Wegovy pill, FDA-approved oral GLP-1 | Compounded tirzepatide (GLP-1/GIP) |
| Regulatory note | FDA-approved finished medication; not compounded | Compounded medications are not FDA-approved |
| Starting price | Get started online for just $39 | $179 month-to-month; $159 three-month; $149 six-month; $139 12-month |
| Shipping and subscription | Not verified on captured page | Free subscription shipping; online refills and delivery |
| Clinician review | Treatment only when licensed clinician determines medically appropriate | Treatment only when licensed clinician determines medically appropriate |
| Best for | Online GLP-1 weight loss care, injection-averse patients | People who confirm eligibility, total cost, renewal terms and state availability |
Shipping, refills, and practical terms
bmiMD explicitly offers free shipping on every subscription order and online refills and delivery. Ro.co captured pages did not verify shipping, fees, membership or cancellation details. The bmiMD source also highlights 24 7 clinician access and online refill convenience.
Price sensitivity and commitments
If ongoing cost is the top priority, bmiMD presents lower long-term monthly equivalents with a 12-month option at $139 per month but the source cautions that the lowest price requires a 12-month commitment and that total prepaid charges should be confirmed. Ro.co warns that branded medications like Wegovy cost significantly more than compounded alternatives and that ongoing medication pricing varies.
Check Ro.co starting price details
Clinician review, eligibility, and safety language
Both sources specify that treatment is available only when a licensed clinician determines it is medically appropriate. Both sources include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co emphasizes the regulatory assurance of prescribing an FDA-approved finished product rather than a compounded medication.
Confirm bmiMD eligibility and terms
Conclusion: Choose based on regulatory preference and budget
Ro.co vs bmiMD boils down to a choice between regulatory assurance and oral FDA-approved medication versus lower long-term monthly equivalents with compounded tirzepatide and free shipping. Ro.co is the only mainstream platform here offering the Wegovy oral pill and starts at $39 to get started online. bmiMD offers multiple billing options from $179 down to $139 per month with free subscription shipping and 24 7 clinician access, with the caveat that the lowest price requires a 12-month commitment.
Choose Ro.co if you want access to the FDA-approved Wegovy oral GLP-1, prefer a finished, non compounded product, and value brand trust and regulatory clarity. Choose bmiMD if you prioritize lower long-term monthly cost with multi-month plans, free shipping, and online refills, and you confirm eligibility and prepaid terms before enrolling.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
